Hugh M. Cramer
Papers
1
Total Citations
43
H-Index
1
About
Hugh M. Cramer is a pharmaceutical scientist whose research centers on bioanalytical method development and the critical role of plasma protein binding in drug discovery. His most-cited work, a 2021 paper on optimizing a high-throughput solid-phase microextraction system, has garnered 43 citations for its practical advancement in measuring drug-plasma protein interactions. This contribution is vital for determining the free concentration of a drug in the bloodstream—a key parameter influencing efficacy and safety. Cramer’s research streamlines a traditionally complex assay, enabling faster, more reliable screening during early drug development. By enhancing throughput without sacrificing accuracy, his work directly supports the preclinical evaluation of new therapeutics, helping researchers identify promising candidates more efficiently. His achievements reflect a focused commitment to bridging analytical chemistry and pharmacology, providing tools that accelerate the journey from laboratory discovery to clinical application.
Research Focus
Key Achievements
Top Papers
- 1